StoneX Group’s ProShares Ultra Health Care RXL Stock Holding History

StoneX Group’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	+4,341	New	+$203K	0.01%	1073

Other funds holding RXL

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

StoneX Group's RXL Position: Q2 2026 in Review

StoneX Group opened a new position in ProShares Ultra Health Care (RXL) in Q2 2026: 4,341 shares worth $209K. The stake represents 0.01% of the portfolio and ranks #1073 among its holdings.

16 funds tracked by Wall St. Rank hold RXL as of Q2 2026.

StoneX Group held 4,341 shares of ProShares Ultra Health Care worth $209K as of Q2 2026.
ProShares Ultra Health Care was a new StoneX Group position in Q2 2026.
ProShares Ultra Health Care made up 0.01% of StoneX Group's portfolio in Q2 2026, its #1073 holding.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.